199 related articles for article (PubMed ID: 9717824)
21. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
Neves M; Ciofu C; Larousserie F; Fleury J; Sibony M; Flahault A; Soubrier F; Gattegno B
J Urol; 2002 Mar; 167(3):1276-81. PubMed ID: 11832713
[TBL] [Abstract][Full Text] [Related]
22. [Telomerase activity and determination of cancer in urological neoplasias using exfoliated urinary cells: in situ TRAP assay and its application].
Ohyashiki K; Yahata N; Iwama H; Aizawa T; Miki M
Nihon Rinsho; 1998 May; 56(5):1299-303. PubMed ID: 9613141
[TBL] [Abstract][Full Text] [Related]
23. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
Halling KC; King W; Sokolova IA; Karnes RJ; Meyer RG; Powell EL; Sebo TJ; Cheville JC; Clayton AC; Krajnik KL; Ebert TA; Nelson RE; Burkhardt HM; Ramakumar S; Stewart CS; Pankratz VS; Lieber MM; Blute ML; Zincke H; Seelig SA; Jenkins RB; O'Kane DJ
J Urol; 2002 May; 167(5):2001-6. PubMed ID: 11956427
[TBL] [Abstract][Full Text] [Related]
24. Molecular staging of pelvic surgical margins after radical prostatectomy: comparison of RT-PCR for prostate-specific antigen and telomerase activity.
Straub B; Müller M; Krause H; Goessl C; Schrader M; Heicappell R; Miller K
Oncol Rep; 2002; 9(3):545-9. PubMed ID: 11956625
[TBL] [Abstract][Full Text] [Related]
25. Telomerase activity in human bladder cancer.
Lin Y; Miyamoto H; Fujinami K; Uemura H; Hosaka M; Iwasaki Y; Kubota Y
Clin Cancer Res; 1996 Jun; 2(6):929-32. PubMed ID: 9816252
[TBL] [Abstract][Full Text] [Related]
26. Comparison of screening methods in the detection of bladder cancer.
Ramakumar S; Bhuiyan J; Besse JA; Roberts SG; Wollan PC; Blute ML; O'Kane DJ
J Urol; 1999 Feb; 161(2):388-94. PubMed ID: 9915409
[TBL] [Abstract][Full Text] [Related]
27. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
[TBL] [Abstract][Full Text] [Related]
28. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
[TBL] [Abstract][Full Text] [Related]
29. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
[TBL] [Abstract][Full Text] [Related]
30. [Expression of telomerase and its RNA in nasopharyngeal carcinoma].
Wen Z; Xiao J; Tang F; Tian Y; Zhao S; Chen B
Chin Med J (Engl); 2000 Jun; 113(6):525-8. PubMed ID: 11775871
[TBL] [Abstract][Full Text] [Related]
31. Expression of telomerase activity, telomerase RNA component and telomerase catalytic subunit gene in lung cancer.
Chen W; Xiong X; Zhou H; Zhou Q
Chin Med J (Engl); 2002 Feb; 115(2):290-2. PubMed ID: 11940351
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.
Botchkina GI; Kim RH; Botchkina IL; Kirshenbaum A; Frischer Z; Adler HL
Clin Cancer Res; 2005 May; 11(9):3243-9. PubMed ID: 15867219
[TBL] [Abstract][Full Text] [Related]
33. Telomerase in (pre)neoplastic cervical disease.
Wisman GB; De Jong S; Meersma GJ; Helder MN; Hollema H; de Vries EG; Keith WN; van der Zee AG
Hum Pathol; 2000 Oct; 31(10):1304-12. PubMed ID: 11070123
[TBL] [Abstract][Full Text] [Related]
34. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Bian W; Xu Z
Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
[TBL] [Abstract][Full Text] [Related]
35. Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease overexpress the telomerase RNA template (hTR).
Heine B; Hummel M; Demel G; Stein H
J Pathol; 1999 Jun; 188(2):139-45. PubMed ID: 10398156
[TBL] [Abstract][Full Text] [Related]
36. [Significance of a simple assay of urine telomerase activity for the detection of bladder cancer].
Iwabuchi I; Mori K; Yamamoto H; Hatakeyama S; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Suzuki T; Ohyama C
Hinyokika Kiyo; 2010 Oct; 56(10):551-7. PubMed ID: 21063158
[TBL] [Abstract][Full Text] [Related]
37. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
Moussa O; Abol-Enein H; Bissada NK; Keane T; Ghoneim MA; Watson DK
J Urol; 2006 Jun; 175(6):2312-6. PubMed ID: 16697865
[TBL] [Abstract][Full Text] [Related]
39. Relevance of urine telomerase in the diagnosis of bladder cancer.
Sanchini MA; Gunelli R; Nanni O; Bravaccini S; Fabbri C; Sermasi A; Bercovich E; Ravaioli A; Amadori D; Calistri D
JAMA; 2005 Oct; 294(16):2052-6. PubMed ID: 16249419
[TBL] [Abstract][Full Text] [Related]
40. [Telomerase activity as marker of superficial tumor of the bladder].
Arias Fúnez F; Fernández Fernández E; Escudero Barrilero A; Moyano Jato A; Caso Peláez E
Arch Esp Urol; 2000 Apr; 53(3):231-6. PubMed ID: 10851728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
